{
  "ptid_time": "021_S_4245_2011-12-21",
  "img_path": "/data/qiuhui/data/adni/images/021_S_4245/2011-12-21/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 67,444 mm³, 75.1% above the reference mean. With a Z-score of 1.80 (96.4th percentile), this represents moderate enlargement; whole brain volume measures 979,880 mm³, 9.2% below the reference mean. With a Z-score of -1.20 (11.6th percentile), this represents mild atrophy. ",
  "text_data": "Age is 73.6 years. Gender is Male. Education: 19 years. Handedness: Right. Race: Asian. Medical history: Psychiatric; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Respiratory; Dermatologic-Connective Tissue; Endocrine-Metabolic; Renal-Genitourinary; Allergies or Drug Sensitivities; Smoking. MMSE: 26.0. MoCA: 20.0. Logical Memory: 9.0. Laboratory findings: Total Bilirubin: 0.90 (significant elevated); Creatine Kinase: 198.00 (significant elevated); Phosphorus: 2.60 (significant reduced). APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 0.93 SUVR (mild reduced); Amyloid beta: 924.40 pg/mL (normal ); Total tau: 125.00 pg/mL (mild reduced); Phosphorylated tau: 9.22 pg/mL (moderate reduced). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The data shows moderate ventricular enlargement and mild whole brain atrophy, which are structural changes often seen in neurodegenerative conditions. The MMSE score of 26 is borderline normal, but the MoCA score of 20 suggests cognitive impairment, while CSF biomarkers (Aβ normal, reduced T-tau and P-tau) do not strongly support Alzheimer's pathology.  \n\n**Diagnosis:** **MCI (Mild Cognitive Impairment)**  \n**Confidence:** **Medium** (due to conflicting biomarker results and cognitive scores)",
  "timestamp": "2025-07-26T01:41:21.489317"
}